Elena Rossini

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Journal: Neurology

Published: May 26, 2026

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences

Published: October 06, 2025

Sporadic late-onset nemaline myopathy (SLONM): Data from a case series and literature review of 144 patients.

Sporadic late-onset nemaline myopathy (SLONM): Data from a case series and literature review of 144 patients.

Journal: Autoimmunity reviews

Published: August 06, 2025

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

Journal: Brain sciences

Published: July 18, 2025

Response to letter to the editor: "Emergent role of complement inhibitors in myasthenic crisis" (CNN-D-25-2224).

Response to letter to the editor: "Emergent role of complement inhibitors in myasthenic crisis" (CNN-D-25-2224).

Journal: Clinical neurology and neurosurgery

Published: July 17, 2025

Response to comment on: "Emergent role of complement inhibitors in myasthenic crisis - Complement for crisis, FcRn for continuity (CNN-D-25-2177)".

Response to comment on: "Emergent role of complement inhibitors in myasthenic crisis - Complement for crisis, FcRn for continuity (CNN-D-25-2177)".

Journal: Clinical neurology and neurosurgery

Published: July 17, 2025

Myasthenic syndromes: mistaking genetic for acquired.

Myasthenic syndromes: mistaking genetic for acquired.

Journal: Practical neurology

Published: July 01, 2025

Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how.

Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how.

Journal: Clinical neurology and neurosurgery

Published: March 28, 2025

Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.

Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.

Journal: Journal of neurology

Published: March 12, 2025

Prevalence and Geographical Distribution of Patients With Congenital Myasthenic Syndromes in the United Kingdom.

Prevalence and Geographical Distribution of Patients With Congenital Myasthenic Syndromes in the United Kingdom.

Journal: Muscle & nerve

Published: February 27, 2025

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Journal: Journal of neurology

Published: February 01, 2025

Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience.

Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience.

Journal: Frontiers in immunology

Published: January 17, 2025

Showing 1-12 of 19

Last Updated: 09/26/2026